Haaijer-Ruskamp FM - Search Results

1

Does comorbidity explain trends in prescribing of newer antihypertensive agents?

Greving JP, Denig P, van der Veen WJ, Beltman FW, Sturkenboom MC, de Zeeuw D, Haaijer-Ruskamp FM. Greving JP, et al. J Hypertens. 2004 Nov;22(11):2209-15. doi: 10.1097/00004872-200411000-00025. J Hypertens. 2004. PMID: 15480107

2

Differential effects of comorbidity on antihypertensive and glucose-regulating treatment in diabetes mellitus--a cohort study.

Voorham J, Haaijer-Ruskamp FM, Wolffenbuttel BH, de Zeeuw D, Stolk RP, Denig P. Voorham J, et al. PLoS One. 2012;7(6):e38707. doi: 10.1371/journal.pone.0038707. Epub 2012 Jun 5. PLoS One. 2012. PMID: 22679516 Free PMC article.

3

Trends in prescribing for heart failure in Dutch primary care from 1996 to 2000.

Pont LG, Sturkenboom MC, van Gilst WH, Denig P, Haaijer-Ruskamp FM. Pont LG, et al. Pharmacoepidemiol Drug Saf. 2003 Jun;12(4):327-34. doi: 10.1002/pds.809. Pharmacoepidemiol Drug Saf. 2003. PMID: 12812013 Free article.

4

Uptake of angiotensin II receptor blockers in the treatment of hypertension.

Greving JP, Denig P, van der Veen WJ, Beltman FW, Sturkenboom MC, de Zeeuw D, Haaijer-Ruskamp FM. Greving JP, et al. Eur J Clin Pharmacol. 2005 Jul;61(5-6):461-6. doi: 10.1007/s00228-005-0924-7. Epub 2005 May 24. Eur J Clin Pharmacol. 2005. PMID: 15912393

5

Determinants for the adoption of angiotensin II receptor blockers by general practitioners.

Greving JP, Denig P, van der Veen WJ, Beltman FW, Sturkenboom MC, Haaijer-Ruskamp FM. Greving JP, et al. Soc Sci Med. 2006 Dec;63(11):2890-8. doi: 10.1016/j.socscimed.2006.07.019. Epub 2006 Sep 7. Soc Sci Med. 2006. PMID: 16959390

6

Claims in advertisements for antihypertensive drugs in a Dutch medical journal.

Greving JP, Denig P, de Zeeuw D, Haaijer-Ruskamp FM. Greving JP, et al. J Hypertens. 2007 Mar;25(3):713-22. doi: 10.1097/HJH.0b013e328012662a. J Hypertens. 2007. PMID: 17278989 Free article.

7

Association between performance measures and glycemic control among patients with diabetes in a community-wide primary care cohort.

Sidorenkov G, Voorham J, Haaijer-Ruskamp FM, de Zeeuw D, Denig P. Sidorenkov G, et al. Med Care. 2013 Feb;51(2):172-9. doi: 10.1097/MLR.0b013e318277eaf5. Med Care. 2013. PMID: 23222526 Free article.

8

Treatment quality indicators predict short-term outcomes in patients with diabetes: a prospective cohort study using the GIANTT database.

Sidorenkov G, Voorham J, de Zeeuw D, Haaijer-Ruskamp FM, Denig P. Sidorenkov G, et al. BMJ Qual Saf. 2013 Apr;22(4):339-47. doi: 10.1136/bmjqs-2012-001203. Epub 2013 Feb 5. BMJ Qual Saf. 2013. PMID: 23386729

9

Validity of performance indicators for assessing prescribing quality: the case of asthma.

Pont LG, Denig P, van der Molen T, van der Veen WJ, Haaijer-Ruskamp FM. Pont LG, et al. Eur J Clin Pharmacol. 2004 Jan;59(11):833-40. doi: 10.1007/s00228-003-0696-x. Epub 2003 Nov 18. Eur J Clin Pharmacol. 2004. PMID: 14624323

10

Physician, organizational, and patient factors associated with suboptimal blood pressure management in type 2 diabetic patients in primary care.

Schaars CF, Denig P, Kasje WN, Stewart RE, Wolffenbuttel BH, Haaijer-Ruskamp FM. Schaars CF, et al. Diabetes Care. 2004 Jan;27(1):123-8. doi: 10.2337/diacare.27.1.123. Diabetes Care. 2004. PMID: 14693977

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

168 results

Search Page

Filters